SEC Form 4 · accession 0001654954-17-004855
NAVIDEA BIOPHARMACEUTICALS, INC. · NAVB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael M Goldberg
Officer — President & CEO · Director
Period of report
May 16, 2017
Accepted (ET)
May 16, 2017 · 5:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000810509
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $.001 par value | May 16, 2017 | A | 106,021 | $0.4599 | A | 5,921,023 | D |
Table II — derivative securities
No Table II lines on this filing.